Literature DB >> 7904139

Expression of the GST pi gene and response to tamoxifen therapy in locally advanced breast carcinomas.

F Dorion-Bonnet1, N Quénel, J M Coindre, L Mauriac, F Bonichon, M Durand, J Wafflart, J A Moscow, K H Cowan, N Gualde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7904139     DOI： 10.1111/j.1749-6632.1993.tb17207.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  2 in total

1.  Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases.

Authors:  I Soubeyran; N Quénel; L Mauriac; M Durand; F Bonichon
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

2.  pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.

Authors:  I Soubeyran; N Quénel; J M Coindre; F Bonichon; M Durand; J Wafflart; L Mauriac
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.